Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies

Laura Bujoreanu Bezman,1,2 Carmen Tiutiuca,1,3 Geanina Totolici,1,3 Nicoleta Carneciu,1,2 Florin Ciprian Bujoreanu,4 Diana Andreea Ciortea,5,6 Elena Niculet,2,4 Ana Fulga,3,4 Anamaria Madalina Alexandru,4,7 Daniela Jicman Stan,4 Aurel Nechita5,6 1Department of Ophthalmology, “Sfantul Apostol Andrei” Emergency Clinical Hospital, Galati, Romania; 2Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, “Dunărea de Jos” University, Galati, Romania; 3Clinical Surgical Department, Faculty of Medicine and Pharmacy, “Dunărea de Jos” University, Galati, Romania; 4Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, “Dunărea de Jos” University, Galati, Romania; 5Department of Pediatrics, “Sfantul Ioan” Emergency Clinical Hospital for Children, Galati, Romania; 6Clinical Medical Department, Faculty of Medicine and Pharmacy, “Dunărea de Jos” University, Galati, Romania; 7Department of Neonatology, “Sfantul Apostol Andrei” Emergency Clinical Hospital, Galati, RomaniaCorrespondence: Carmen Tiutiuca, Clinical Surgical Department, Faculty of Medicine and Pharmacy, “Dunărea de Jos” University, Galati, 800008, Romania, Tel +40741330788, Email tiutiuca_carmen@yahoo.com Florin Ciprian Bujoreanu, Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, “Dunărea de Jos” University, Galati, 800008, Romania, Tel +40741395844, Email florin.bujoreanu@gmail.comAbstract: Retinopathy of prematurity (ROP) is a vasoproliferative disorder with an imminent risk of blindness, in cases where early diagnosis and treatment are not performed. The doctors’ constant motivation to give these fragile beings a chance at life with optimal visual acuity has never stopped, since Terry first described this condition. Thus, throughout time, several specific advancements have been made in the management of ROP. Apart from the most known risk f